JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ALO
3501
DELISTED
Alio Gold Inc
ALO
| $1.12M | ﹤0.01% |
304,650
+188,400
| +162% | +$682K |
2017 Q2
2 quarters
|
|
|
EUMV
3502
DELISTED
iShares Edge MSCI Min Vol Europe ETF
EUMV
| $1.12M | ﹤0.01% |
44,026
+2,165
| +5% | +$54.7K |
2016 Q2
6 quarters
|
|
3503
eHealth
EHTH
$22.2M
| $1.11M | ﹤0.01% |
63,836
+41,096
| +181% | +$919K |
2016 Q2
6 quarters
|
|
|
MITL
3504
DELISTED
Mitel Networks Corporation
MITL
| $1.11M | ﹤0.01% |
134,573
+63,811
| +90% | +$520K |
2017 Q3
1 quarter
|
|
|
DBVT
3505
CALL
DBV Technologies S.A. American Depositary Shares
DBVT
$705M
| $1.11M | ﹤0.01% |
+4,500
| New | +$1.3M |
2017 Q4
0 quarters
|
|
|
DBVT
3506
PUT
DBV Technologies S.A. American Depositary Shares
DBVT
$705M
| $1.11M | ﹤0.01% |
+4,500
| New | +$1.3M |
2017 Q4
0 quarters
|
|
3507
CALL
Goodyear
GT
$1.45B
| $1.1M | ﹤0.01% |
+34,200
| New | +$1.09M |
2017 Q4
0 quarters
|
|
|
LFC
3508
DELISTED
China Life Insurance Company Ltd.
LFC
| $1.1M | ﹤0.01% |
70,531
+66,839
| +1,810% | +$1.09M |
2015 Q4
8 quarters
|
|
3509
iShares MSCI Philippines ETF
EPHE
$129M
| $1.1M | ﹤0.01% |
28,342
+6,490
| +30% | +$242K |
2014 Q4
12 quarters
|
|
3510
iShares MSCI Indonesia ETF
EIDO
$420M
| $1.1M | ﹤0.01% |
38,600
+15,600
| +68% | +$421K |
2014 Q4
12 quarters
|
|
|
FPRX
3511
CALL
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.1M | ﹤0.01% |
+50,000
| New | +$1.61M |
2017 Q4
0 quarters
|
|
3512
CALL
Alkermes
ALKS
$6.8B
| $1.09M | ﹤0.01% |
+20,000
| New | +$1.02M |
2017 Q4
0 quarters
|
|
|
3513
PUT
Alkermes
ALKS
$6.8B
| $1.09M | ﹤0.01% |
+20,000
| New | +$1.02M |
2017 Q4
0 quarters
|
|
3514
Pacer Developed Markets International Cash Cows 100 ETF
ICOW
$1.72B
| $1.09M | ﹤0.01% |
37,300
-10,000
| -21% | -$285K |
2017 Q2
2 quarters
|
|
3515
PUT
M&T Bank
MTB
$31.4B
| $1.09M | ﹤0.01% |
+6,400
| New | +$1.06M |
2017 Q4
0 quarters
|
|
3516
Sonic Automotive
SAH
$2.02B
| $1.09M | ﹤0.01% |
59,160
-6,908
| -10% | -$141K |
2016 Q2
6 quarters
|
|
|
VNTR
3517
DELISTED
Venator Materials PLC
VNTR
| $1.09M | ﹤0.01% |
49,306
-242,589
| -83% | -$5.57M |
2017 Q3
1 quarter
|
|
3518
Floor & Decor
FND
$4.9B
| $1.09M | ﹤0.01% |
22,338
-87,969
| -80% | -$3.55M |
2017 Q2
2 quarters
|
|
3519
PUT
Corning
GLW
$138B
| $1.09M | ﹤0.01% |
+34,000
| New | +$1.07M |
2017 Q4
0 quarters
|
|
3520
iShares US Pharmaceuticals ETF
IHE
$1.61B
| $1.09M | ﹤0.01% |
21,135
-876
| -4% | -$45K |
2014 Q1
15 quarters
|
|
3521
First Trust Consumer Staples AlphaDEX Fund
FXG
$201M
| $1.08M | ﹤0.01% |
22,249
-1,686
| -7% | -$78.9K |
2013 Q2
18 quarters
|
|
3522
Toyota
TM
$217B
| $1.08M | ﹤0.01% |
8,513
-449
| -5% | -$56K |
2013 Q2
18 quarters
|
|
3523
Constellium
CSTM
$3.34B
| $1.08M | ﹤0.01% |
97,020
-180,091
| -65% | -$1.92M |
2014 Q3
13 quarters
|
|
3524
MidCap Financial Investment
MFIC
$720M
| $1.08M | ﹤0.01% |
63,330
+9,138
| +17% | +$164K |
2013 Q2
18 quarters
|
|
3525
Lexicon Pharmaceuticals
LXRX
$810M
| $1.07M | ﹤0.01% |
108,826
+4,785
| +5% | +$49.7K |
2015 Q3
9 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.